TRPV1 and diabetes mellitus: Indeed, preliminary data from our laboratory clearly indicate that as a function of diabetes, guanfacine suppresses the increase in mRNA expression of TRPV1 and TRPA1 in several regions of the central nervous system including pons, LSSC, and DRG (unpublished data).